[1] GUANGHONG J,ADAM W C,JAMES R S.Diabetic cardiomyopathy:a hyperglycaemia- and insulin-resistance-induced heart disease[J].Diabetologia,2017,61(61):21-28.
[2] SIHEM B,ABEL E D.Diabetic cardiomyopathy revisited[J].Circulation,2007,115(125):3213-3223.
[3] CHRISTIAN R,JOHANN B.Of mice and men:models and mechanisms of diabetic cardiomyopathy[J].Basic Res Cardiol,2018,114(111):112.
[4] MURTAZA G,VIRK H U H,KHALID M,et al.Diabetic cardiomyopathy - a comprehensive updated review[J].Prog Cardiovasc Dis,2019,62(64):315-326.
[5] DIETER A K,ÅSA B G.Unbreak my heart:targeting mitochondrial autophagy in diabetic cardiomyopathy[J].Antioxid Redox Signal,2015,22(17):1527-1544.
[6] CECILIA G,RYAN H,GABRIELLA B,et al.Diabetic cardiomyopathy modelling using induced pluripotent stem cell derived cardiomyocytes:recent advances and emerging models[J].Stem Cell Rev Rep,2018,15(11):13-22.
[7] CHENGJU T,JINGHUA Z,JINFENG L,et al.Ryanodine receptor and immune-related molecules in diabetic cardiomyopathy[J].Esc Heart Failure,2021,8(4):2637-2646.
[8] TRACEY M,LIFEN L,CINDY L,et al.T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans[J].Arterioscler Thromb Vasc Biol,2014,34(12):2637-2643.
[9] CHANGYAN Z,LIYUN H,HUAN Y,et al.Changes of Th17 cells,regulatory T cells,Treg/Th17,IL-17 and IL-10 in patients with type 2 diabetes mellitus:a systematic review and Meta-analysis[J].Endocrine,2022,76(72):263-272.
[10] SANDQUIST I,KOLLS J.Update on regulation and effector functions of Th17 cells[J].F1000Res,2018,7:205. A.Decr1和Hmgcs2基因的mRNA水平;B.Decr1和Hmgcs2基因的蛋白质水平 图11 DCM大鼠中Decr1和Hmgcs2的表达水平变化
[11] NALBANT A.IL-17,IL-21,and IL-22 cytokines of T helper 17 cells in cancer[J].J Interferon Cytokine Res,2019,39(1):56-60.
[12] 王艳.T细胞在糖尿病肾病发展中作用的研究进展[J].现代医学,2022,50(11):1481-1485.
[13] RAMON I K G,RYAN K,ERIKA L P.Unraveling the complex interplay between T cell metabolism and function[J].Annu Rev Immunol,2018,36:461-488.
[14] NICOLE M C,MARK B,HONGBO C.Metabolic coordination of T cell quiescence and activation[J].Nat Rev Immunol,2019,20(21):55-70.
[15] HONGXING S,LEWIS ZHICHANG S.Metabolic regulation of TH17 cells[J].Mol Immunol,2019,109:181-187.
[16] YINLIANG C,JINBAO Y,YING W,et al.Identification and analysis of hub genes in diabetic cardiomyopathy:potential role of cytochrome P450 1A1 in mitochondrial metabolism and STZ-induced myocardial dysfunction[J].Front Cardiovasc Med,2022,9:835244.
[17] PETER L,STEVE H.WGCNA:an R package for weighted correlation network analysis[J].BMC Bioinformatics,2008,9:559.
[18] KIN-YING T.Identification of differential gene expression by high throughput analysis[J].Comb Chem High Throughput Screen,2000,3(3):235-241.
[19] SIWEN Z,XIAOKUN G,SHUO Y,et al.The alterations in and the role of the Th17/Treg balance in metabolic diseases[J].Front Immunol,2021,12:678355.
[20] NÚRIA M,THERESE V,KIM W,et al.Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia[J].J Immunol,2014,193(199):4457-4468.
[21] XIAOYU P,XUEQING Z,JIANGLI B,et al.Effects of high-fat diet on cardiovascular protein expression in mice based on proteomics[J].Diabetes Metab Syndr Obes,2023,16:873-882.
[22] LEI D,YANG X,WENJUN Z,et al.Weighted gene co-expression network analysis identifies ANGPTL4 as a key regulator in diabetic cardiomyopathy via FAK/SIRT3/ROS pathway in cardiomyocyte[J].Front Endocrinol(Lausanne),2021,12:705154.
[23] GARY D L,QUTUBA G K,KIM L H,et al.Ketone metabolism in the failing heart[J].Biochim Biophys Acta Mol Cell Biol Lipids,2020,1865(1812):158813.
[24] PATRYCJA P,PETER A C.Multi-dimensional roles of ketone bodies in fuel metabolism,signaling,and therapeutics[J].Cell Metab,2017,25(22):262-284.
[25] KUNAL S,SANKET K S,NIRAL P,et al.High fat diet upregulates fatty acid oxidation and ketogenesis via intervention of PPAR-γ[J].Cell Physiol Biochem,2018,54(56):1255.
[26] OLIVER J R,ANDREW A,JACK J M,et al.Noninvasive in vivo assessment of cardiac metabolism in the healthy and diabetic human heart using hyperpolarized 13C MRI[J].Circ Res,2020,126(126):725-736.
[27] MIN C,HAO W,YAJUAN A,et al.Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis[J].Front Endocrinol(Lausanne),2024,15:1185062. |